Bax inhibitor-1 (BI-1) is an anti-apoptotic protein located in the endoplasmic reticulum (ER). The role of BI-1 has been studied in different physiopathological models including ischemia, diabetes, liver regeneration and cancer. However, fundamental knowledge about the effects of BI-1 deletion on the proteome is lacking. To further explore this protein, we compared the levels of different proteins in bi-1 -/and bi-1 +/+ mouse tissues by two-dimensional electrophoresis (2-DE) and mass spectrometry (MS). In several bi-1 -/mice, glucose-regulated protein 75 (GRP75/mortalin/ PBP74/mthsp70), peroxiredoxin6 (Prx6) and fumarylacetoacetate hydrolase (FAH) showed a pI shift that could be attributed to post-translational modifications. Seleniumbinding protein 2 (SBP2) and ferritin light chain 1 levels were significantly increased. Phosphatidylethanolaminebinding protein-1 (PEBP-1) was dramatically decreased in bi-1 -/mice, which was confirmed by Western blotting. The phosphorylation of GRP75, Prx6 and FAH were compared between bi-1 +/+ and bi-1 -/mice using liver tissue lysates. Of these three proteins, only one exhibited modified phosphorylation; Tyr phosphorylation of Prx6 was increased in bi-1 -/mice. Our protein profiling results provide fundamental knowledge about the physiopathological function of BI-1.
INTRODUCTION
Bax inhibitor-1 (BI-1) is an anti-apoptotic protein with six or seven transmembrane domains. BI-1 was discovered during a screen for suppressors of Bax-induced cell death. Overexpressed BI-1 provides protection against apoptosis, whereas BI-1 antisense RNA promotes apoptosis of some tumor cell lines (Xu and Reed, 1998) . However, more recently the protective role of BI-1 was found to be focused on specific stress conditions such as endoplasmic reticulum (ER) stress, as opposed to all apoptotic stimuli (Chae et al., 2004) .
Immunofluorescence microscopy and subcellular fractionation studies have demonstrated that BI-1 is located in the ER (Xu and Reed, 1998) . ER is an important organelle where protein synthesis, folding and modification take place and the secretory pathway begins (Rutkowski and Kaufman, 2004) . The ER can initiate apoptosis when the accumulation of unfolded proteins or the inhibition of ER-Golgi transport results in an ER stress response (Oyadomari et al., 2002) . Reactive oxygen species (ROS) are generated in the ER through oxidative protein folding (Lee et al., 2007) . ER responds to the accumulation of unfolded proteins in its lumen by activating intracellular signal transduction pathways cumulatively called the unfolded protein response (UPR) (Ron and Walter, 2007) .
BI-1 can inhibit ROS accumulation in the ER by modifying heme oxygenase 1 (HO-1) expression (Lee et al., 2007) and reduce ROS products in the ER through regulation of cytochrome P450 2E1 (Kim et al., 2009) . BI-1 also increases Ca 2+ leakage from the ER (Kim et al., 2008) , possibly in a pHdependent manner. Although BI-1 regulates ER stress-related apoptosis, its role during ER stress and the resulting signal pathways are only now beginning to be revealed. Furthermore, recent efforts to understand the role of BI-1 have focused on ischemia/reperfusion using liver tissues from knock-out mouse models bi-1 +/+ and bi-1 -/-. The ischemic stress-associated damage was more severe in bi-1 knock-out mice compared to wildtype mice (Bailly-Maitre et al., 2006) . When mice were exposed to hypoxic stress, the infarction size was significantly larger in bi-1 -/than it was in bi-1 +/+ mice (Chae et al., 2004) . Although one study found highly efficient regeneration of damaged liver in bi-1 knock-out mice (Bailly-Maitre et al., 2007) , other studies have mainly focused on the protective functions of BI-1 in in vitro and in vivo systems (Bailly-Maitre et al., 2006; Chae et al., 2004; Dohm et al., 2006) .
It is important to obtain basic information to elucidate the mechanisms of the effects of BI-1 on various disease models. Here we utilized a proteomics approach. This technology is ideal for detecting changes in protein expression as it allows for comparison of two or more samples on a relatively global level while requiring little or no knowledge about pathways influenced by the experimental conditions (Skynner et al., 2002) . http://molcells.org This is particularly important for studies of genetically altered mice, since it is virtually impossible to predict all pathways that are likely to be affected. We used two-dimensional electrophoresis (2-DE) and mass spectrometry to identify changes in the proteomes of bi-1-genetically altered mouse models. In this study we identified differential protein expressions and modifications in tissues from bi-1 knockout compared to those of wildtype mice.
MATERIALS AND METHODS

Materials
Linear immobilized pH gradient (IPG) strips (24-cm, pH 3-10 NL) and IPG buffer (pH 3-10 NL) were purchased from GE Healthcare (Sweden). Trifluoroacetic acid (TFA), tributylphosphine (TBP), and acetonitrile (ACN) were purchased from Fluka (Switzerland). Antibodies against β-actin, GRP75, Prx6, SBP2 and phosphothreonine were acquired from Santa Cruz Biotechnology (USA). Anti-phosphotyrosine was obtained from BD Transduction Laboratories (USA). Anti-phosphoserine was purchased from Invitrogen Life Technologies (USA). Antibodies against FAH and ferritin light chain were purchased from Abcam (USA). Anti-PEBP-1 was purchased from Invitrogen Life Technologies (USA). All other chemicals used in 2-D electrophoresis were ultra pure grade and were purchased from Amresco (USA). All chemicals using in western blotting were of analytical grade and purchased from Sigma-Aldrich (USA).
Animals
The bi-1 +/+ and bi-1 -/mice used in this study have been described previously (Chae et al., 2004) . Mice were housed in cages in a temperature-controlled animal facility with a 12 h light/dark cycle.
Sample collection
Five independent tissues (brain, heart, lung, liver and kidney) from eight-week-old mice were snap frozen in liquid nitrogen and stored at -80°C for further analysis.
Preparation of protein extracts for proteomics studies
Frozen tissue samples were lysed in 0.5 ml 7 M-urea/2 Mthiourea buffer (7 M urea, 2 M thiourea, 4% CHAPS, 100 mM DTT, 40 mM Tris, and trace amounts of bromophenol blue) with 5 μl protease inhibitor mix (Amersham, USA). Briefly, tissues were sonicated ten times using an Ultrasonic processor VCX 130 (Sonic & Materials, USA) for approximately 10 s at 30 s intervals. Following sonication, 10 μl of 1,000 U/ml DNase was added to the lysate, and the mixture was vortexed for 30 min and then centrifuged at 12,000 rpm for 45 min to remove any undissolved material. The resulting supernatant was used as the protein lysate.
A 2-D clear-up kit (GE Healthcare, Sweden) was used to clarify the lysate according to the manufacturer's protocol. The protein concentration was measured using the Bradford assay with BSA as the standard (Bradford, 1976) . All of the samples were stored at -80°C.
Two-dimensional electrophoresis methodology
Two-dimensional electrophoresis (2-DE) was carried out for male and female (n = 5 each) bi-1 +/+ mice, as well as for the corresponding bi-1 -/group (n = 5 for both males and females). To assure reproducibility and to prevent variations due to the technique, all 2-DE gels were carried out under exactly the same conditions with five independent tissue samples (brain, heart, lung, liver and kidney) from each mouse and two experimental replicates.
Isoelectric focusing (IEF) was carried out with 24-cm, pH 3-10, non linear IPG strips at 20°C using the Ettan IPGphor II isoelectric focusing system (GE Healthcare, Sweden). Proteins (1 mg) were mixed with rehydration buffer (7 M urea, 2 M thiourea, 4% CHAPS, 100 mM DTT, 2% IPG buffer and trace amounts of bromophenol blue), and loaded onto first-dimension IPG gel strips. The IPG strips were rehydrated with the samples overnight (18-20 h). The IEF protocol was as follows: (i) 100 V, 3 h, step and hold mode; (ii) 200 V, 2 h, step and hold mode; (iii) 500 V, 1 h, step and hold mode; (iv) 1,000 V, 1 h, step and hold mode; (v) 2000 V, 1 h, step and hold mode; (vi) 4,500 V, 1 h, gradient mode; (vii) 8,000 V, 1 h, gradient mode; (viii) 8,000 V, 11 h, step and hold mode until an approximately 100,000 V total was reached. After IEF was completed, the strips were stored at -80°C.
Prior to second-dimension SDS/PAGE, the frozen strips were subjected to one-step equilibration for 25 min in TBP solution (6 M urea, 37.4 mM Tris-HCl, 20% glycerol, 2.5% acrylamide, 2% SDS, 5 mM TBP) in a shaker. The IPG strips were then positioned onto a 9-17% gradient 1.5 mm SDS/PAGE gel and fixed in place with a 0.5% agarose overlay. SDS/PAGE molecular weight standard (3 μl) on filter paper was embedded directly on the top of the gel. Gels were run in an Ettan DALTsix electrophoresis system (GE Healthcare, Sweden) at 15 mA/gel for 1 h and then at 60 mA/gel until the bromophenol blue dye reached the bottom of the gel.
In-gel protein visualization using Coomassie blue staining After SDS/PAGE, the gels were washed in ultrapure water and fixed in 40% EtOH and 10% acetic acid solution for 1 h. The gels were then stained overnight with Coomassie blue G-250 staining solution (17% (w/v) ammonium sulfate, 3% (v/v) phosphoric acid, 34% (v/v) methanol, and 0.1% (w/v) Coomassie blue G-250 in ultrapure water). After staining, the gels were washed several times in ultrapure water over a period of more than 4 h.
Image analysis
Gels were scanned with a UMAX Powerlook 1120 scanner (Maxium Technologies, Taiwan). The images were saved in tagged image file format (TIFF) and imported to Melanie 7.0 Software (GeneBio, Switzerland). Image analysis software was used for spot detection, quantification, and analysis according to the manufacturer's instructions. Briefly, the basic analysis scheme consisted of five steps: detection of spots, identification of landmark proteins, aligning and matching of gel spots, quantification of matched spots, and manual inspection of the spots to verify accuracy of the matching.
Spot detection parameters were carefully adjusted. First, the smooth parameter was set to a value of 2, allowing for the detection of all real spots and the differentiation of overlapping spots. The minimum area was then established to eliminate spots that had an area smaller than 30 pixels. Finally, the saliency parameter was experimentally adjusted to 2 in order to filter out artifacts. The detection parameters were recorded and applied to other gels. The spot volume was used as the analysis parameter for quantifying protein expression.
Spot excision and in-gel digestion
After identification of the spots of interest, protein spots were excised from Coomassie blue-stained second-dimension gels using a P200 yellow pipette tip with the end cut off. The excised
